Stemline Therapeutics Inc (NASDAQ:STML)
During the Trading Day
| 11.86 |  -0.54 / -4.35% |
Data as of 3:59pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 11.96 |  +0.0981 / +0.83% |
Volume: 1.6K |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 71.0K | |
| Depreciation And Amortization | 0.00 | 0.00 | -- | 76.7K | ||
| Operating Expenses | Gross Income | 0.00 | 0.00 | 0.00 | -- | -- |
| General Expenses | 2.3M | 2.7M | 6.5M | 24.0M | ||
| Research And Development | 1.3M | 1.6M | 3.4M | 16.2M | ||
| Total Operating Expenses | 2.3M | 2.7M | 6.5M | 24.1M | ||
| Non-Operating Expenses | Operating Income | -2.3M | -2.7M | -6.5M | -24.0M | |
| Extraordinary Credit | 21.9K | 0.00 | 0.00 | 30.4K | ||
| Extraordinary Charge | 0.00 | -9.7K | 0.00 | 0.00 | ||
| Interest Expense On Debt | 69.5K | 98.6K | 118.8K | 516.9K | ||
| Other Expenses | 463.0K | 46.7K | 301.6K | 250.3K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -1.8M | -2.8M | -6.3M | -24.2M | |
| Net Income | -1.8M | -2.8M | -6.3M | -24.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 7.0M | 7.0M | 7.5M | 10.3M | |
| Shares To Calculate EPS Diluted | 7.0M | 7.0M | 7.5M | 10.3M | ||
| Earnings Per Share | EPS | $2.81 | -$0.80 | -$1.82 | -$2.35 | |
| EPS Diluted | -$0.26 | -$0.40 | -$0.84 | -$2.35 | ||
.
